Switch to:
More From Other Websites
Time to Shift Your Focus Aug 28 2016
Saturday links: bad intentions Aug 27 2016
Lung cancer doctors eye Merck's Keytruda over Bristol's Opdivo Aug 25 2016
Merck Offers Value and Steady Dividend Growth Aug 24 2016
Health-care sector trails broader market as pricing issues reinflamed Aug 24 2016
Merck Potential Blockbuster Drug, Key Acquisition Make It a Good Bet for Investors Aug 23 2016
[$$] Pfizer’s Medivation Deal Latest in Long Line of Similar Acquisitions Aug 22 2016
Monday links: work and drudgery Aug 22 2016
[$$] Pfizer's Medivation Deal Latest in Long Line of Similar Acquisitions Aug 22 2016
Pfizer Will Buy Cancer Drugmaker Medivation For $14 Billion Aug 22 2016
Curbing Excessive Exuberance May be Premature Aug 21 2016
How Much Medivation Can Really Fetch in a Buyout Aug 18 2016
Merck Among Drug Giants Looking To Buy Medivation, Says Report Aug 17 2016
Gilead Sciences: Still Dominating Hepatitis C But… Aug 17 2016
How Will Merck (MRK) Stock React to Potential Medivation Bid? Aug 17 2016
How Did Merck’s Animal Health Segment Perform? Aug 17 2016
Lux Research Names Mike Coyne as New CEO Aug 17 2016
Remicade Is Driving Down Merck’s Immunology Franchise Aug 16 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK